This site is intended for US residents 18 years of age and older

INDICATIONS AND USAGE

SPRYCEL® (dasatinib) is a prescription medicine used to treat:

  • adults with newly diagnosed Philadelphia chromosome–positive (Ph+) chronic myeloid leukemia (CML) in chronic phase
  • adults with Ph+ CML who no longer benefit from, or did not tolerate, other treatment, including imatinib
  • adults with Ph+ acute lymphoblastic leukemia (Ph+ ALL) who no longer benefit from, or did not tolerate, other treatment
  • children 1 year of age and older with Ph+ CML in chronic phase
  • children 1 year of age and older with newly diagnosed Ph+ ALL in combination with chemotherapy

It is not known if SPRYCEL is safe and effective in children under 1 year of age.

SPRYCEL for Ph+ CML in Adults

How is SPRYCEL® (dasatinib) used to treat adults with Ph+ CML in CP?

If you or a loved one have been prescribed or are considering SPRYCEL for the treatment of Philadelphia chromosome–positive (Ph+) chronic myeloid leukemia (CML), you probably have a few questions. Fortunately, you’ve come to the right place. Here, you will find information about SPRYCEL and how it may be used to treat adults with newly diagnosed Ph+ CML in chronic phase.

You can learn more about:

SPRYCEL is a prescription medicine used to treat:

  • adults with newly diagnosed Ph+ CML in chronic phase
  • adults with Ph+ CML who no longer benefit from, or did not tolerate, other treatment, including imatinib
  • adults with Ph+ acute lymphoblastic leukemia (Ph+ ALL) who no longer benefit from, or did not tolerate, other treatment

Remember--Ph+ CML is an ongoing disease. There is no cure. Take your medicine the way your healthcare provider prescribes so it has the best chance to work for you.

SPRYCEL® (dasatinib) digital handbook SPRYCEL® (dasatinib) digital handbook

BECOME AN INSPIRATION

“I found that becoming an engaged patient and keeping up with my test results and my progress helped me feel more in control.” – Lee, SPRYCEL patient

WATCH LEE’S STORY
Lee, a SPRYCEL® (dasatinib) patient, standing on a beach
Lee, a SPRYCEL® (dasatinib) patient, standing on a beach
Back
to Top